Management of Elevated BUN in an 87-Year-Old Patient
An 87-year-old patient with a BUN of 34.4 mg/dL requires immediate assessment of volume status, kidney function, and potential causes of azotemia, with consideration for nephrology consultation if acute kidney injury is present.
Initial Assessment
- Evaluate volume status carefully, as both dehydration and fluid overload can contribute to elevated BUN 1
- Measure additional laboratory parameters including:
Clinical Significance of BUN 34.4 mg/dL
- BUN >20 mg/dL is considered clinically significant and a risk factor for increased mortality in various conditions 2, 3
- In critically ill patients, BUN >28 mg/dL is associated with adverse outcomes even after correction for other risk factors (HR 3.34; 95% CI 2.89-3.86) 3
- Elderly patients are particularly vulnerable to elevated BUN due to lower muscle mass and often have disproportionate elevations compared to creatinine 4
Determine Etiology
Calculate BUN:creatinine ratio:
Common causes of elevated BUN in elderly patients include:
Management Algorithm
For hypovolemic patients:
For euvolemic or hypervolemic patients:
For severe azotemia (BUN >100 mg/dL) with uremic symptoms:
Monitoring and Follow-up
- Maintain accurate intake/output records to track fluid balance 1
- Monitor BUN, creatinine, and electrolytes every 4-6 hours initially, then daily as clinically indicated 1
- Calculate "Age + BUN" score:
- For this 87-year-old patient with BUN of 34.4, the score is 121.4
- Score ≥90 is associated with increased risk of medical deterioration (positive predictive value 39.8%, negative predictive value 89.5%) 7
Special Considerations for Elderly Patients
- Elderly patients (>75 years) are more susceptible to disproportionate BUN elevation due to lower muscle mass 4
- Mortality is higher in elderly patients with elevated BUN, particularly when multiple comorbidities are present 4, 3
- Even modest BUN elevations (>20 mg/dL) in elderly patients with acute coronary syndromes are associated with increased mortality, independent of creatinine-based estimates of GFR 5